Human immunodeficiency virus type 1 (HIV-1)- and Epstein-Barr virus- specific cytotoxic T lymphocyte precursors exhibit different kinetics in HIV- 1-infected persons

Journal of Infectious Diseases

Volumn 174, Issue 1, 1996, Pages 34-45

  Geretti, Anna M ^b   Dings, Marlinda E M ^b   Van Els, Cécile A C M ^b   Van Baalen, Carel A ^b   Wijnholds, Folko J ^b   Borleffs, Jan C C ^b   Osterhaus, Albert D M E ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYTOKINE; GAG PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOBLASTOID CELL LINE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOPROLIFERATIVE DISEASE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROLYMPHOCYTE;

EID: 0030035741     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/174.1.34     Document Type: Article

References (14)

1. + T-cell immune responses and viral replication. AIDS 1993;7(suppl 2):S81-5.
2. Cease KB, Berzofsky JA. Toward a vaccine for AIDS: the emergence of immunobiology-based vaccine development. Annu Rev Immunol 1994; 12:923-89.
3. Koup RA, Safrit JT, Cao Y, et al. Temporal association of cellular immune response with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 1994;68:4650-5.
4. Safrit JT, Andrews CA, Zhu T, Ho DD, Koup RA. Characterization of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte clones isolated during acute seroconversion: recognition of autologous virus sequences within a conserved immunodominant epitope. J Exp Med 1994;179:463-72.
5. Johnson RP, Walker BD. Cytotoxic T lymphocytes in human immunodeficiency virus infection: responses to structural proteins. Curr Top Microbiol Immunol 1994;189:35-63.
6. Gotch FM, Nixon DF, Alp N, McMichael AJ, Borysiewicz LK. High frequency of memory and effector gag-specific cytotoxic T lymphocytes in HIV-seropositive individuals. Int Immunol 1990;2:707-12.
7. Koup RA, Pikora CA, Luzuriaga K, et al. Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with P17 and P24 specificities. J Exp Med 1991;174:1593-600.
8. Lamhamedi-Cherradi S, Culmann-Penciolelli B, Guy B, et al. Qualitative and quantitative analysis of human cytotoxic T-lymphocyte responses to HIV-1 proteins. AIDS 1992;6:1249-58.
9. Carmichael A, Jin X, Sissons P, Borysiewicz LK. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J Exp Med 1993;177:249-56.
10. Autran B, Plata F, Debre P. MHC-restricted cytotoxicity against HIV. J Acquir Immune Defic Syndr 1991;4:361-7.
11. + cell anti-HIV activity correlates with the clinical state of the infected individual. J Clin Invest 1991;87:1462-6.
12. + T lymphocytes of patients with AIDS maintain normal broad cytolytic function despite the loss of human immunodeficiency virus-specific cytotoxicity. Proc Natl Acad Sci USA 1990;87:4818-22.
13. Bourgault I, Gomez A, Gomard E, Levy JP. Limiting dilution analysis of the HLA restriction of anti-Epstein-Barr virus specific cytolytic T lymphocytes. Clin Exp Immunol 1991;84:501-7.
14. Pantaleo G, Grouses C, Demarest JF, et al. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993;362:355-8.